Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Clinical Research: Head For A 'Carried Out-In-India' Tag
Sep 15, 2006
India has an enriched pool of English educated, highly qualified and skilled medical professionals, suited for R &D activities. The large Indian populace serves as a perfect sample space for studying the impact of diseases in the backdrop of the marginal exposure to healthcare facilities.
India is also home to a heterogeneous blend of different gene types like Caucasians, Australoids and Mogoloids. Drug companies are interested to use this microcosm for testing the impact of new drugs.
In the present scenario, globally the total size of outsourced clinical trails in the Pharmaceutical market stands at US$221 billion. This market is growing at an annual growth rate, ranging between 9-11 %. India accounts for a major chunk of this market standing at US$285 million.
The market research report, “Opportunities in Indian Pharma Sector”, by RNCOS finds that India is fast assuming the position of the most favored destination for clinical trials. The raison d’etre is cost cutting for competitive edge.
The estimated size of clinical trial conducted in India, whether directly or through research organizations in the Pharmaceutical market is projected to stand at US$ 2 billion by 2010.
The research report also addresses the issues and facts that are critical to business success, like:
- What are the emerging trends in the Pharmaceutical sector in India?
- What are the key regulations and the policy environment in the industry?
- What are the future trends of the Pharmaceutical market in India?
- Who are the Key players in the Pharmaceutical Market in India?
- What are the Opportunities and Threats in pharmaceuticals sector?
- How is the market affected by other factors prevailing in the economy?
The report incorporates detailed data and analysis that will help investors and business heads to comprehend the changing dynamics of the Pharmaceutical market in India.
For more information visit: http://www.rncos.com/Report/IM055.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Novel Parkinson Disease Drugs Aid in Reducing “Off” Time in Patients
- Nanotechnology Mediated Targeted Drug Delivery for Cancer Treatment: Gaining Momentum
- Stem Cell Therapy – A Breakthrough in Parkinson’s Disease Treatment
- Lentiviral Vectors: Emerging as a Promising Tool for T-Cell Immunotherapy
- Nanosized Drug Delivery Systems Revolutionizing Entire Drug Therapy Strategy
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact